Antipyretic TRIZ Cases

An immunoassay detects intestinal alkaline phosphatase levels to identify early disease stages before radiographic signs appear, reducing diagnostic delay.

Albumin-binding lipophilic siRNA conjugates extend circulation half-life and sustain protein silencing in inflamed joints.

Specific compounds block TLR2-mediated NF-kB activation to treat LCMV infections while minimizing harmful inflammatory responses.

Iontophoresis controls cannabinoid absorption speed to prevent systemic side effects while ensuring localized pain relief.

Aluminum-mediated chelation stabilizes 18F-labeled peptides, eliminating purification steps and reducing labeling time.

Benzazepine derivative acts as a TLR8 agonist to activate myeloid dendritic cells, overcoming regulatory T cell suppression in cancer therapy.

Anti-OX40 antibodies enhance anti-tumor immunity by specifically binding OX40, resolving the trade-off between immune effectiveness and treatment complexity.

Leveraging inverse blood-tissue biomarker correlation for early canine arthritis detection and dietary management.

Phage display isolates specific peptides targeting VAP-1, resolving low specificity in conventional anti-inflammatory therapies.

Hinge mutations prevent intra-chain disulfide bonding in alpha4beta7 antibodies, reducing immunogenicity while maintaining therapeutic efficacy.

Structural optimization of small molecule compounds inhibits phosphodiesterase 4 while reducing vomiting and liver toxicity side effects.

Engineered human antibodies utilize specific heavy and light chain variable regions to neutralize interleukin-1 beta.

Grafting murine complementarity determining regions onto human framework regions reduces immunogenicity while maintaining binding affinity.

N-linked glycosylation extends serum half-life of Fc fusion proteins, reducing frequent dosing needs while maintaining biological activity.

Combining topical rose bengal with systemic PDE4 inhibitors targets hyperproliferative skin disorders through segmented therapy.

Tisochrysis lutea treats inflammatory bowel disease by inhibiting inflammation while regenerating the intestinal mucosa without chemical side effects.

Segmented amino acid sequences target conserved B7:CD28 epitopes to resolve reliability and complexity trade-offs in T-cell activation control.

Immersion of Chrysanthemum morifolium activates endogenous enzymes to hydrolyze glycosides into aglycones before solvent extraction.

Three-dimensional suspension culture forms embryoid bodies from pluripotent stem cells for high-yield mesenchymal stem cell production.

Selecting mesenchymal stem cells with defined surface markers overcomes insufficient barrier function in umbilical cord derived therapies.

A medicinal composition combines Matricaria recutita, Psidium guajava L., and Plantago major L. extracts to inhibit pathogen growth without preservatives.

Light exposure and organic acid treatment induce earthworms to excrete digestive contents and skin dirt for purification.

A pharmaceutical composition of short chain fatty acids in a specific ratio modulates the immune response to reduce cytokine levels.

Incorporating a FIG4-derived 3'-untranslated region element into artificial nucleic acid molecules stabilizes the RNA structure.

Redirected regulatory T cells use chimeric receptors to bind target antigens and trigger localized immune suppression.